Low-voltage-gated (LVA) calcium channels (CaV3.1-CaV3.3), also known as T-type channels, are central regulators of neuronal activity and promising drug targets for the treatment of pain and epilepsy [1]. This evidence concerns the gene CACNA1G and epilepsy.